Xu Han
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$9.2MFederal grants as PI15 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
15 awards · $9.2M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 18, 2025 | NIH | SBIR Phase II Establishment of a First-in-Class Biocompatible and Efficient Cryopreservation Technology Platform for the Next Generation of Cell-Based Therapeutics in Regenerative Medicine and Drug Discovery | $922K | CRYOCRATE LLC |
| Sep 10, 2024 | NIH | SBIR Phase II Establishment of a First-in-Class Biocompatible and Efficient Cryopreservation Technology Platform for the Next Generation of Cell-Based Therapeutics in Regenerative Medicine and Drug Discovery | $941K | CRYOCRATE LLC |
| Jul 20, 2023 | NIH | SBIR Phase II Innovation of Biobanking for Cellular Adoptive Immunotherapies Based on a First-in-Class Biocompatible Cryopreservation Technology for T and NK Cells and Their CAR-Engineered Products | $864K | CRYOCRATE LLC |
| Apr 28, 2023 | NIH | SBIR Phase II Innovation of Skin Banking and Transplantation Based on a First-in-Class Biocompatible Cryopreservation Technology | $736K | CRYOCRATE LLC |
| Sep 15, 2022 | NIH | SBIR Phase II Innovation of Biobanking for Cellular Adoptive Immunotherapies Based on a First-in-Class Biocompatible Cryopreservation Technology for T and NK Cells and Their CAR-Engineered Products | $899K | CRYOCRATE LLC |
| Aug 29, 2022 | NIH | SBIR Phase II Late-stage Preclinical Development and cGMP Production of a First-in-Class Cornea Cryopreservation Kit Based on FDA Feedback | $727K | CRYOCRATE LLC |
| May 6, 2022 | NIH | SBIR Phase II Innovation of Skin Banking and Transplantation Based on a First-in-Class Biocompatible Cryopreservation Technology | $752K | CRYOCRATE LLC |
| Aug 27, 2021 | NIH | SBIR Phase II Late-stage Preclinical Development and cGMP Production of a First-in-Class Cornea Cryopreservation Kit Based on FDA Feedback | $754K | CRYOCRATE LLC |
| Aug 12, 2020 | NIH | SBIR Phase II An Ultra-fast Cooling Device for Vitrification and Cryopreservation of Cells and Tissues | $751K | CRYOCRATE LLC |
| Jul 25, 2020 | NIH | SBIR Phase II An Ultra-fast Cooling Device for Vitrification and Cryopreservation of Cells and Tissues | $313K | CRYOCRATE LLC |
| May 11, 2020 | NIH | SBIR Phase I A Novel Cryopreservation Technology for Large Skin Grafts to Facilitate Tissue Banking and Allograft Transplantations | $160K | CRYOCRATE LLC |
| Sep 1, 2019 | NIH | SBIR Phase II An Ultra-fast Cooling Device for Vitrification and Cryopreservation of Cells and Tissues | $815K | CRYOCRATE LLC |
| Aug 3, 2018 | NIH | SBIR Phase I In-Situ Cryopreservation Without Cryoprotectants | $292K | CRYOCRATE LLC |
| Jul 15, 2015 | NIH | SBIR Phase I An Ultra-fast Cooling Device for Vitrification and Cryopreservation of Cells and Tissues | $153K | CRYOCRATE LLC |
| Jul 13, 2015 | NIH | SBIR Phase I An Ultra-fast Cooling Device for Vitrification and Cryopreservation of Cells and Tissues | $153K | CRYOCRATE LLC |
1 patents as inventor
- US CRYOCRATE LLC—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#80
Awards as PI#46
Patents#273
Companies
- CRYOCRATE LLCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.